13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 33 holding rows worth $1,050,374,000.
- Accession
- 0001567619-18-000858
- Filer
- CIK 1587114
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 35 entries on the cover page, a total value of $1,050,374,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,050,372,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FIBROGEN INC | 31572Q808 | COM | 2,017,250 | $126,280,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 6,250,073 | $119,501,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,943,164 | $115,401,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,464,067 | $97,390,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,904,675 | $71,065,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 199,500 | $55,798,000 | thousands by filing date | |
| CELGENE CORP | 151020904 | COM | 585,000 | $46,461,000 | thousands by filing date | call |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 2,671,161 | $41,670,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,961,147 | $36,274,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 1,450,606 | $29,955,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S | 04351P901 | CALL | 447,000 | $29,735,000 | thousands by filing date | call |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 2,236,387 | $27,373,000 | thousands by filing date | |
| UNITY BIOTECHNOLOGY INC | 91381U101 | COM | 1,680,644 | $25,310,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,272,198 | $22,009,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q908 | CALL | 350,000 | $21,910,000 | thousands by filing date | call |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,509,671 | $21,437,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 1,538,088 | $20,764,000 | thousands by filing date | |
| GILEAD SCIENCES INC | 375558903 | COM | 292,600 | $20,728,000 | thousands by filing date | call |
| IMMUNE DESIGN CORP. | 45252L103 | Common Stock | 4,437,600 | $20,191,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 412,871 | $15,792,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 890,808 | $14,529,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 1,039,500 | $12,682,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X908 | COM CL A | 577,600 | $11,044,000 | thousands by filing date | call |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 3,887,407 | $11,001,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 2,500,000 | $9,975,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396908 | CALL | 148,100 | $5,807,000 | thousands by filing date | call |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 298,100 | $5,750,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 450,400 | $4,945,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 1,150,000 | $3,048,000 | thousands by filing date | |
| ONCONOVA THERAPEUTICS INC COM PAR | 68232V306 | Stock | 7,500,000 | $3,034,000 | thousands by filing date | |
| PHAXIAM THERAPEUTICS S A | 29604W108 | SPONSORED ADR | 153,964 | $1,734,000 | thousands by filing date | |
| APTINYX INC | 03836N103 | COM | 41,037 | $992,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 412,000 | $787,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-18-000858 | this filing | 2018-08-14 | acceptance time not in the bulk data set |